Key result
Application of blebbistatin or mechanosensitive channel blockers to fibrotic monolayers increased longitudinal conduction velocity from 14.4 to 35.9 cm/s and transverse velocity from 4.1 to 10.3 cm/s.
Population
Monolayers of cocultured myofibroblasts and neonatal rat ventricular cells
Comparison
Application of excitation-contraction uncoupler… vs Untreated and transforming growth…
Design
Preclinical
Authors
Loading...
Should not change clinical practice in fibrotic hearts; hypothesis-generating for mechanosensitive channel targeting in arrhythmogenesis.
Myofibroblast-myocyte mechanical interactions impair cardiac conduction via increased mechanosensitive channel activation, suggesting a novel mechanism for arrhythmogenesis in fibrotic hearts.
Thompson et al. (2011) studied Cardiac fibrosis (in vitro model). Blebbistatin, gadolinium, or streptomycin vs. Untreated (control) and transforming growth factor-β-treated (fibrotic) monolayers was evaluated on Longitudinal conduction velocity, transverse conduction velocity, and normalized action potential upstroke velocity. Application of blebbistatin or mechanosensitive channel blockers to fibrotic monolayers increased longitudinal conduction velocity from 14.4 to 35.9 cm/s and transverse velocity from 4.1 to 10.3 cm/s.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: